865 related articles for article (PubMed ID: 28245323)
41. Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia.
Hijiya N; Hudson MM; Lensing S; Zacher M; Onciu M; Behm FG; Razzouk BI; Ribeiro RC; Rubnitz JE; Sandlund JT; Rivera GK; Evans WE; Relling MV; Pui CH
JAMA; 2007 Mar; 297(11):1207-15. PubMed ID: 17374815
[TBL] [Abstract][Full Text] [Related]
42. Second neoplasms after megavoltage radiation for pediatric tumors.
Gold DG; Neglia JP; Dusenbery KE
Cancer; 2003 May; 97(10):2588-96. PubMed ID: 12733158
[TBL] [Abstract][Full Text] [Related]
43. Trends in treatment of childhood cancer and subsequent primary neoplasm risk.
Cesen Mazic M; Reulen RC; Jazbec J; Zadravec Zaletel L
Radiol Oncol; 2022 Aug; 56(3):380-389. PubMed ID: 35848608
[TBL] [Abstract][Full Text] [Related]
44. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry.
Rihani R; Bazzeh F; Faqih N; Sultan I
Cancer; 2010 Sep; 116(18):4385-94. PubMed ID: 20549819
[TBL] [Abstract][Full Text] [Related]
45. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
46. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
47. Second primary neoplasms in survivors of Wilms' tumour--a population-based cohort study from the British Childhood Cancer Survivor Study.
Taylor AJ; Winter DL; Pritchard-Jones K; Stiller CA; Frobisher C; Lancashire ER; Reulen RC; Hawkins MM;
Int J Cancer; 2008 May; 122(9):2085-93. PubMed ID: 18196579
[TBL] [Abstract][Full Text] [Related]
48. Second cancer risk following Hodgkin's disease: a 20-year follow-up study.
van Leeuwen FE; Klokman WJ; Hagenbeek A; Noyon R; van den Belt-Dusebout AW; van Kerkhoff EH; van Heerde P; Somers R
J Clin Oncol; 1994 Feb; 12(2):312-25. PubMed ID: 8113838
[TBL] [Abstract][Full Text] [Related]
49. Morbidity and Mortality Associated With Meningioma After Cranial Radiotherapy: A Report From the Childhood Cancer Survivor Study.
Bowers DC; Moskowitz CS; Chou JF; Mazewski CM; Neglia JP; Armstrong GT; Leisenring WM; Robison LL; Oeffinger KC
J Clin Oncol; 2017 May; 35(14):1570-1576. PubMed ID: 28339329
[TBL] [Abstract][Full Text] [Related]
50. Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
Bassal M; Mertens AC; Taylor L; Neglia JP; Greffe BS; Hammond S; Ronckers CM; Friedman DL; Stovall M; Yasui YY; Robison LL; Meadows AT; Kadan-Lottick NS
J Clin Oncol; 2006 Jan; 24(3):476-83. PubMed ID: 16421424
[TBL] [Abstract][Full Text] [Related]
51. Risk of a Second Kidney Carcinoma Following Childhood Cancer: Role of Chemotherapy and Radiation Dose to Kidneys.
de Vathaire F; Scwhartz B; El-Fayech C; Allodji RS; Escudier B; Hawkins M; Diallo I; Haddy N
J Urol; 2015 Nov; 194(5):1390-5. PubMed ID: 26143112
[TBL] [Abstract][Full Text] [Related]
52. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk.
Wong FL; Boice JD; Abramson DH; Tarone RE; Kleinerman RA; Stovall M; Goldman MB; Seddon JM; Tarbell N; Fraumeni JF; Li FP
JAMA; 1997 Oct; 278(15):1262-7. PubMed ID: 9333268
[TBL] [Abstract][Full Text] [Related]
53. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
Hisada M; Chen BE; Jaffe ES; Travis LB
J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
[TBL] [Abstract][Full Text] [Related]
54. The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma.
Tward JD; Wendland MM; Shrieve DC; Szabo A; Gaffney DK
Cancer; 2006 Jul; 107(1):108-15. PubMed ID: 16708354
[TBL] [Abstract][Full Text] [Related]
55. Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma.
Hodgson DC; Gilbert ES; Dores GM; Schonfeld SJ; Lynch CF; Storm H; Hall P; Langmark F; Pukkala E; Andersson M; Kaijser M; Joensuu H; Fosså SD; Travis LB
J Clin Oncol; 2007 Apr; 25(12):1489-97. PubMed ID: 17372278
[TBL] [Abstract][Full Text] [Related]
56. Secondary colorectal carcinoma after childhood cancer.
Nottage K; McFarlane J; Krasin MJ; Li C; Srivastava D; Robison LL; Hudson MM
J Clin Oncol; 2012 Jul; 30(20):2552-8. PubMed ID: 22665546
[TBL] [Abstract][Full Text] [Related]
57. Breast cancer in female survivors of Wilms tumor: a report from the national Wilms tumor late effects study.
Lange JM; Takashima JR; Peterson SM; Kalapurakal JA; Green DM; Breslow NE
Cancer; 2014 Dec; 120(23):3722-30. PubMed ID: 25348097
[TBL] [Abstract][Full Text] [Related]
58. Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study.
Henderson TO; Oeffinger KC; Whitton J; Leisenring W; Neglia J; Meadows A; Crotty C; Rubin DT; Diller L; Inskip P; Smith SA; Stovall M; Constine LS; Hammond S; Armstrong GT; Robison LL; Nathan PC
Ann Intern Med; 2012 Jun; 156(11):757-66, W-260. PubMed ID: 22665813
[TBL] [Abstract][Full Text] [Related]
59. Increased risk of chronic lymphocytic leukaemia among cancer survivors in the Netherlands: increased detection, causal factors or both?
van den Broek EC; Liu L; Posthuma EF; Janssen-Heijnen ML; Coebergh JW; Soerjomataram I
Ann Hematol; 2014 Jan; 93(1):157-62. PubMed ID: 24381068
[TBL] [Abstract][Full Text] [Related]
60. Pooled Analysis of Meningioma Risk Following Treatment for Childhood Cancer.
Withrow DR; Anderson H; Armstrong GT; Hawkins M; Journy N; Neglia JP; de Vathaire F; Tucker MA; Inskip PD; Brenner AV; Stovall MA; Diallo I; Berrington de Gonzalez A; Veiga LHS
JAMA Oncol; 2022 Dec; 8(12):1756-1764. PubMed ID: 36201196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
